David R. McAvoy
CIK 1758842 · EVP, Chief Legal Officer · last filed 2025-09-09
David R. McAvoy is an EVP, Chief Legal Officer who has filed 16 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider bought $21.0K of TEVA on Sep 9, 2025. Across all open-market trades the lifetime net is −$3.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $451.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$451.1K
4
16
-$3.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEVA | EVP, Chief Legal Officer | 13,027 | $34.63 | $451.1K | -$55.3K | 4 | 2025-09-09 |
| Fresh Tracks Therapeutics, Inc. (FRTX) Delisted | Gen Counsel, CCO, & Secretary | 23,729 | $0.94 | $22.2K | $0 | 2 | 2023-10-04 |
| Fresh Tracks Therapeutics, Inc. (BBI) Delisted | General Counsel and CCO | 142,859 | $2.35 | $335.7K | $52.2K | 9 | 2022-05-09 |
| ENDOCYTE INC (ECYT) Delisted | General Counsel | 0 | — | — | $0 | 1 | 2018-12-21 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-09 | TEVA | Buy (P) | +1,113 | $21.0K | EDGAR |
| 2025-03-07 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2025-03-06 | TEVA | Mixed | +11,914 | -$76.3K | EDGAR |
| 2024-03-05 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2023-10-04 | Fresh Tracks Therapeutics, Inc. (FRTX) Delisted | Mixed | +12,642 | -$7.2K | EDGAR |
| 2023-01-26 | Fresh Tracks Therapeutics, Inc. (FRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-09 | Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-27 | Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Buy (P) | +18,124 | $12.1K | EDGAR |
| 2021-06-14 | Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-19 | Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Buy (P) | +26,602 | $21.3K | EDGAR |